While leading a pharmaceutical company, Samira Sakhia (BCom鈥�90, DPA鈥�94, MBA鈥�01) is also volunteering her expertise in the broader 平特五不中 community and supporting students in realizing their...
Congratulations to Samira Sakhia (BCom鈥�90, DPA鈥�94, MBA鈥�01), who will take on a new challenge as President and Chief Executive Officer of Knight Therapeutics Inc., a Montreal-based company focused...
Knight Therapeutics has announced the resignation of its chief financial officer, as the company鈥檚 president and Desautels International Faculty Advisory Board member, Samira Sakhia (BCom鈥�90, DPA...
At the Bloom Burton & Co Healthcare Investor Conference this May, Knight Therapeutics鈥� president, Samira Sakhia (BCom鈥�90, DPA鈥�94, MBA鈥�01) will be giving the Montreal-based specialty...
Knight Therapeutics Inc. (TSX: GUD) ("Knight"), a leading Canadian specialty pharmaceutical company, today announced that Samira Sakhia, former CFO of Paladin Labs Inc. ("Paladin"), will be joining...
Crescita Therapeutics Inc.聽(Crescita or the Company), a commercial dermatology company with a portfolio of over-the-counter and prescription products for the treatment and care of skin diseases and...
Samira Sakhia, president of Knight Therapeutics, has joined聽Crescita Therapeutics Inc.鈥檚聽board of directors.聽 Prior to her current role, she was the chief financial officer of Paladin Labs. She...
In its 2016 financial results press release, Mississauga-based Profound Medical announced the appointment of Samira Sakhia (BCom鈥�90, MBA鈥�01) to its Board of Directors. Ms. Sakhia is also a member...
RSS